Management of incidental pulmonary embolism

European Respiratory Journal

Volumn 49, Issue 6, 2017, Pages

  Klok, Frederikus A ^a   Huisman, Menno V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

COMPLICATION; DIAGNOSTIC IMAGING; DISEASE MANAGEMENT; FEMALE; HUMAN; INCIDENTAL FINDING; LUNG EMBOLISM; MIDDLE AGED; NEOPLASM; PRACTICE GUIDELINE; X-RAY COMPUTED TOMOGRAPHY;

ANTICOAGULANTS; DISEASE MANAGEMENT; FEMALE; HUMANS; INCIDENTAL FINDINGS; MIDDLE AGED; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85038447173     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00275-2017     Document Type: Review

References (87)

1. Di Nisio M, Lee AY, Carrier M, et al. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13: 880–883.
2. Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res 2016; 137: 3–10.
3. Liebman HA, O’Connell C. Incidental venous thromboembolic events in cancer patients: what we know in 2016. Thromb Res 2016; 140: Suppl. 1, S18–S20.
4. O’Connell C. How I treat incidental pulmonary embolism. Blood 2015; 125: 1877–1882.
5. Monreal M, Rey-Joly BC, Ruiz MJ, et al. Asymptomatic pulmonary embolism in patients with deep vein thrombosis. Is it useful to take a lung scan to rule out this condition? J Cardiovasc Surg (Torino) 1989; 30: 104–107.
6. Huisman MV, Buller HR, ten Cate JW, et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 498–502.
7. Dorfman GS, Cronan JJ, Tupper TB, et al. Occult pulmonary embolism: a common occurrence in deep venous thrombosis. AJR Am J Roentgenol 1987; 148: 263–266.
8. Moser KM, Fedullo PF, LitteJohn JK, et al. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223–225.
9. Stein PD, Matta F, Musani MH, et al. Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review. Am J Med 2010; 123: 426–431.
10. Boc A, Vene N, Stalc M, et al. Unprovoked proximal venous thrombosis is associated with an increased risk of asymptomatic pulmonary embolism. Thromb Res 2014; 133: 1011–1015.
11. Tzoran I, Saharov G, Brenner B, et al. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs. J Thromb Haemost 2012; 10: 564–571.
12. Jimenez D, Diaz G, Marin E, et al. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Thromb Haemost 2006; 95: 562–566.
13. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 978–981.
14. Kakkar N, Vasishta RK. Pulmonary embolism in medical patients: an autopsy-based study. Clin Appl Thromb Hemost 2008; 14: 159–167.
15. Sweet PH III, Armstrong T, Chen J, et al. Fatal pulmonary embolism update: 10 years of autopsy experience at an academic medical center. JRSM Short Rep 2013; 4: 2042533313489824.
16. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203–205.
17. Bergqvist D, Lindblad B. A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 1985; 72: 105–108.
18. Williams JW, Eikman EA, Greenberg S. Asymptomatic pulmonary embolism. A common event in high risk patients. Ann Surg 1982; 195: 323–327.
19. Keenan AM, Palevsky HI, Steinberg ME, et al. An evaluation of preoperative and postoperative ventilation and perfusion lung scintigraphy in the screening for pulmonary embolism after elective orthopedic surgery. Clin Nucl Med 1991; 16: 13–19.
20. Fredin HO, Arborelius M Jr., Hellekant C. Scintigraphy and chest radiography in the screening of pulmonary embolism after total hip replacement. Respiration 1985; 47: 171–176.
21. Machaalany J, Yam Y, Ruddy TD, et al. Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography. J Am Coll Cardiol 2009; 54: 1533–1541.
22. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277–2284.
23. Bach AG, Meyer HJ, Taute BM, et al. The frequency of incidental pulmonary embolism in different CT examinations. Br J Radiol 2016; 89: 20150737.
24. Sebastian AJ, Paddon AJ. Clinically unsuspected pulmonary embolism-an important secondary finding in oncology CT. Clin Radiol 2006; 61: 81–85.
25. Cronin CG, Lohan DG, Keane M, et al. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. AJR Am J Roentgenol 2007; 189: 162–170.
26. Rita LA, Calandriello L, Maggi F, et al. Prevalence of incidental pulmonary emboli in oncology patients. Radiology 2007; 245: 921–922.
27. Browne AM, Cronin CG, English C, et al. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 2010; 5: 798–803.
28. Tresoldi S, Flor N, Luciani A, et al. Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions. Eur Radiol 2015; 25: 3200–3206.
29. Bach AG, Beckel C, Schurig N, et al. Imaging characteristics and embolus burden of unreported pulmonary embolism in oncologic patients. Clin Imaging 2015; 39: 237–242.
30. Larsen AC, Dabrowski T, Frokjaer JB, et al. Prevalence of venous thromboembolism at diagnosis of upper gastrointestinal cancer. Br J Surg 2014; 101: 246–253.
31. Gladish GW, Choe DH, Marom EM, et al. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 2006; 240: 246–255.
32. Ritchie G, McGurk S, McCreath C, et al. Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax 2007; 62: 536–540.
33. Hui GC, Legasto A, Wittram C. The prevalence of symptomatic and coincidental pulmonary embolism on computed tomography. J Comput Assist Tomogr 2008; 32: 783–787.
34. Storto ML, Di CA, Guido F, et al. Incidental detection of pulmonary emboli on routine MDCT of the chest. AJR Am J Roentgenol 2005; 184: 264–267.
35. Winston CB, Wechsler RJ, Salazar AM, et al. Incidental pulmonary emboli detected at helical CT: effect on patient care. Radiology 1996; 201: 23–27.
36. Gosselin MV, Rubin GD, Leung AN, et al. Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. Radiology 1998; 208: 209–215.
37. Engelke C, Rummeny EJ, Marten K. Pulmonary embolism at multi-detector row CT of chest: one-year survival of treated and untreated patients. Radiology 2006; 239: 563–575.
38. Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma 2004; 56: 727–731.
39. Mueller J, Jeudy J, Poston R, et al. Cardiac CT angiography after coronary bypass surgery: prevalence of incidental findings. AJR Am J Roentgenol 2007; 189: 414–419.
40. Haller S, Kaiser C, Buser P, et al. Coronary artery imaging with contrast-enhanced MDCT: extracardiac findings. AJR Am J Roentgenol 2006; 187: 105–110.
41. Wang J, Wu H, Lv B, et al. Asymptomatic pulmonary embolism following off-pump coronary artery bypass: Outcomes of a prospective observational study. Cardiology 2014; 187: Suppl. 1, 79–80.
42. Staskiewicz G, Czekajska-Chehab E, Adamczyk P, et al. Incidental pulmonary embolism identified in cardiac ECG-MDCT studies: Frequency, predisposing factors. Eur Heart J Cardiovasc Imaging 2012; 13: Suppl. 1, P1067.
43. Bach AG, Schmoll HJ, Beckel C, et al. Pulmonary embolism in oncologic patients: frequency and embolus burden of symptomatic and unsuspected events. Acta Radiol 2014; 55: 45–53.
44. Di Nisio M, Ferrante N, De Tursi M, et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 2010; 104: 1049–1054.
45. Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010; 8: 1716–1722.
46. den Exter PL, Kroft LJ, van der Hulle T, et al. Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced computed tomography imaging in cancer patients. J Thromb Haemost 2013; 11: 1620–1622.
47. Klok FA, van der Bijl N, Eikenboom HC, et al. Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short-term clinical outcome in normotensive patients suspected of having acute pulmonary embolism. J Thromb Haemost 2010; 8: 853–856.
48. van der Bijl N, Klok FA, Huisman MV, et al. Measurement of right and left ventricular function by ECG-synchronized CT scanning in patients with acute pulmonary embolism: usefulness for predicting short-term outcome. Chest 2011; 140: 1008–1015.
49. den Exter PL, van der Hulle T, Hartmann IJ, et al. Reliability of diagnosing incidental pulmonary embolism in cancer patients. Thromb Res 2015; 136: 531–534.
50. O’Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost 2011; 9: 305–311.
51. Pena E, Kimpton M, Dennie C, et al. Difference in interpretation of computed tomography pulmonary angiography diagnosis of subsegmental thrombosis in patients with suspected pulmonary embolism. J Thromb Haemost 2012; 10: 496–498.
52. O’Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol 2006; 24: 4928–4932.
53. Font C, Farrus B, Vidal L, et al. Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients. Ann Oncol 2011; 22: 2101–2106.
54. O’Connell CL, Razavi PA, Liebman HA. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol 2011; 29: 4208–4209.
55. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 1: 1309–1312.
56. Nielsen HK, Husted SE, Krusell LR, et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res 1994; 73: 215–226.
57. van der Hulle T, den Exter PL, Planquette B, et al. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost 2016; 14: 105–113.
58. Sun JM, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. Lung Cancer 2010; 69: 330–336.
59. Dentali F, Ageno W, Giorgi PM, et al. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost 2011; 9: 1081–1083.
60. den Exter PL, Hooijer J, Dekkers OM, et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011; 29: 2405–2409.
61. Callejas MF, Errazuriz JI, Castillo F, et al. Incidental venous thromboembolism detected by PET-CT in patients with cancer: prevalence and impact on survival rate. Thromb Res 2014; 133: 750–755.
62. Chaturvedi S, Sidana S, Elson P, et al. Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer. PLoS One 2014; 9: e94048.
63. Connolly GC, Menapace L, Safadjou S, et al. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer 2013; 14: 713–718.
64. Grigoropoulos NF, Shaw AS, Hampson FA, et al. Incidental pulmonary emboli in lymphoma patients are associated with aggressive disease and poor prognosis. J Thromb Haemost 2010; 8: 2835–2836.
65. Menapace LA, Peterson DR, Berry A, et al. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer. Thromb Haemost 2011; 106: 371–378.
66. Sahut DM, Caumont PA, Planquette B, et al. Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: a case-control study. J Thromb Haemost 2012; 10: 2032–2038.
67. Meinel FG, Nance JW Jr., Schoepf UJ, et al. Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis. Am J Med 2015; 128: 747–759.
68. den Exter PL, van Roosmalen MJ, van den Hoven P, et al. Physicians’ management approach to an incidental pulmonary embolism: an international survey. J Thromb Haemost 2013; 11: 208–213.
69. Franklin JM, Rahman N, Gleeson FV. The clinician’s response to a report of an incidental pulmonary embolism detected on multidetector CT. Postgrad Med J 2011; 87: 746–749.
70. van der Hulle T, Kooiman J, den Exter PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 2014; 12: 320–328.
71. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315–352.
72. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2189–2204.
73. den Exter PL, Zondag W, Klok FA, et al. Efficacy and safety of outpatient treatment based on the Hestia Clinical Decision Rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial. Am J Respir Crit Care Med 2016; 194: 998–1006.
74. van der Hulle T, Dronkers CE, Klok FA, et al. Recent developments in the diagnosis and treatment of pulmonary embolism. J Intern Med 2016; 279: 16–29.
75. Zondag W, Kooiman J, Klok FA, et al. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J 2013; 42: 134–144.
76. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378: 41–48.
77. Font C, Carmona-Bayonas A, Fernández-Martinez A, et al. Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients. J Natl Compr Canc Netw 2014; 12: 365–373.
78. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033–3069.
79. Lee AY, Kamphuisen PW, Meyer G, et al. Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial. JAMA 2015; 314: 677–686.
80. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146–153.
81. van der Wall SJ, Klok FA, den Exter PL, et al. Continuation of LMWH treatment for cancer related venous thromboembolism – a prospective cohort study in daily clinical practice. J Thromb Haemost 2017; 15: 74–79.
82. van der Hulle T, den Exter PL, van den Hoven P, et al. Cohort study on the management of cancer-associated venous thromboembolism aimed at the safety of stopping anticoagulant therapy in patients cured of cancer. Chest 2016; 149: 1245–1251.
83. Peris M, Jimenez D, Maestre A, et al. Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism. Eur Respir J 2016; 48: 1360–1368.
84. Klok FA, Barco S, Konstantinides SV. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism. Thromb Haemost 2017; 117: 1164–1170.
85. Klok FA, Hosel V, Clemens A, et al. Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. Eur Respir J 2016; 48: 1369–1376.
86. Klok FA, Kooiman J, Huisman MV, et al. Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review. Eur Respir J 2015; 45: 201–210.
87. van der Hulle T, den Exter PL, Kooiman J, et al. Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism. J Thromb Haemost 2014; 12: 1116–1120.